Filtering by:
Liver CancerTop Story
Read More
January 4, 2018
Facts & Figures 2018: Rate of Deaths From Cancer Continues Decline
The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society.
September 26, 2017
FDA Approves Opdivo (Nivolumab) for Liver Cancer
The US Food and Drug Administration (FDA) has approved Opdivo (nivolumab), a monoclonal antibody, which is a type of immunotherapy, to treat liver cancer.
April 28, 2017
FDA Approves Stivarga (Regorafenib) for Liver Cancer
The US Food and Drug Administration (FDA) has expanded the approved use of the targeted therapy drug Stivarga (regorafenib) to treat liver cancer.
March 31, 2017
Annual Report to the Nation: Cancer Death Rates Continue to Drop
The death rate from cancer in the United States is continuing to decline among men, women, and children, according to the latest Annual Report to the Nation on the Status of Cancer.